Last reviewed · How we verify
NCT06293508: mBLISS-B
mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public
NA trial testing Standard Health Communication Intervention in Breast Neoplasm Female in 1,180 participants. Terminated before completion.
4 October 2024
Quick facts
| Lead sponsor | Clinical Research Centre, Malaysia |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 1,180 |
| Start date | 30 April 2024 |
| Primary completion | 4 October 2024 |
| Estimated completion | 4 October 2024 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- Standard Health Communication Intervention
- Behavioural Change Health Communication Intervention
Conditions studied
- Breast Neoplasm Female — all drugs for Breast Neoplasm Female →
Sponsor
Clinical Research Centre, Malaysia
Who can join
40 and older, female only, with Breast Neoplasm Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Late-stage presentation of breast cancer cases are on the rise in Malaysia. Encouraging breast screening practices can assist in early breast cancer detection. Literature has proven that behavior interventions in the form of behavior change health communication using social messaging applications is a viable strategy and potentially effective at motivating breast cancer screening among the public. Such studies are scarce in the South East Asian region, particularly in Malaysia, which is the prime motivation for the current study, Based on this promising prospect, a randomized controlled trial will be designed to study the effects of applying persuasive health communication materials to initiate behavior change among a group of Malaysian women. Materials are delivered in the form of a health communication program over a social messaging application to promote breast cancer screening practices, which is either a clinical breast examination, or a mammogram. The investigators hypothesize that Malaysian women who are exposed to such materials that are designed based on behavior science and behavior change principles will be nudged and hence more likely to attend breast cancer screening compared to a control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06293508
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Neoplasm Female
Currently open trials in the same condition.
- NCT07465523 — A Novel Approach in the Evaluation of Breast Masses With Doppler US · recruiting
- NCT06711523 — Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy · Phase 3 · active not recruiting
- NCT05277935 — Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib · NA · recruiting
- NCT06234137 — A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot · NA · recruiting
- NCT04812652 — Digitally Distributed Yoga for Women Treated for Breast Cancer · NA · active not recruiting
Other Clinical Research Centre, Malaysia trials
Trials by the same sponsor.
- NCT05106231 — Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education · NA · completed
- NCT05895721 — Virtual Reality for Generalized Anxiety Disorders · NA · unknown
- NCT05638919 — Real World COVID-19 Antiviral Effectiveness Research · unknown
- NCT06163976 — Prognostic Modelling for Prediction of Mortality and Functional Disability in Critically-ill Elderly Patients · unknown
- NCT06128096 — The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06293508 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Research Centre, Malaysia
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06293508.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing